Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00633152 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
A Phase 2 study of Bacterial Infection, sponsored by Forest Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 13
- Study locations
NCT00633152 is a Phase 2 study of Bacterial Infection that has completed, run by Forest Laboratories. The registered enrollment target is 150 participants, above the 87-participant average among 8 other Bacterial Infection trials with a reported enrollment target (72% higher). The trial reports 13 study locations across 7 states.
The verdict
NCT00633152, a Phase 2 study of Bacterial Infection, has completed, sponsored by Forest Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of complicated skin and skin structure infections in adults.
Conditions Studied
Interventions
- DRUG Aztreonam
- DRUG ceftaroline
- DRUG linezolid
Study Locations (13)
California
- Investigational Site - Buena Park
- Investigational Site - Long Beach
- Investigational Site - Los Angeles
- Investigational Site - Rolling Hills Estate
- Investigational Site - San Diego
Georgia
- Investigational Site - Columbus
- Investigational Site - Savannah
Ohio
- Investigational Site - Columbus
- Investigational Site - Toledo
Florida
- Investigational Site - Atlantis
Minnesota
- Investigational Site - Minneapolis
Montana
- Investigational Site - Butte
New Jersey
- Investigational Site - Somers Point
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00633152
The ClinicalTrials.gov registry entry for NCT00633152 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 87-participant average among 8 other Bacterial Infection trials with a reported enrollment target (72% higher). The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bacterial Infection appearing as the primary indexed condition, and to 3 interventions - of which Aztreonam is the first listed.
NCT00633152 reports 13 study locations spanning 7 distinct geographic areas - top geographies include California, Georgia, Ohio.
Frequently Asked Questions
What is clinical trial NCT00633152 about?
NCT00633152 is a clinical study titled "Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections". The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of complicated skin and skin structure infections in adults.
What is the current status of trial NCT00633152?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2008-02. Estimated completion is 2008-07.
What conditions does trial NCT00633152 study?
This clinical trial studies the following conditions: Bacterial Infection.
What interventions are being tested in trial NCT00633152?
The interventions under investigation include: Aztreonam (DRUG), ceftaroline (DRUG), linezolid (DRUG).
Who is sponsoring clinical trial NCT00633152?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00633152 being conducted?
This trial has 13 study locations across California, Florida, Georgia, Minnesota, Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacterial Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
COMPLETED · Phase 2
-
Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites
COMPLETED · Phase 2
-
Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)
RECRUITING · Phase 4
-
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
RECRUITING · Phase 4
-
Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm
COMPLETED · NA
-
Safety of Intravenous Apramycin in Adults
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.